p38 MAPK inhibition reduces diabetes-induced impairment of wound healing

Diabetes, Metabolic Syndrome and Obesity

Volumn 2, Issue , 2009, Pages 91-100

  Medicherla, Satyanarayana ^a   Wadsworth, Scott ^b   Cullen, Breda ^c   Silcock, Derek ^c   Ma, Jing Y ^a   Mangadu, Ruban ^a   Kerr, Irene ^a   Chakravarty, Sarvajit ^a   Luedtke, Gregory L ^a   Dugar, Sundeep ^a   Protter, Andrew A ^a   Higgins, Linda S ^a  

^a SCIOS INC   (United States)

^b Center for Biomaterials and Advanced Technologies   (United States)

^c JOHNSON AND JOHNSON   (United States)

Author keywords

db db mouse; Diabetic wound healing; Nonresolving healing; p38 MAPK ihibition; Promogran

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE P38; SCIO 469;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG SPECIFICITY; FEMALE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PROTEIN EXPRESSION; TREATMENT OUTCOME; WOUND ASSESSMENT; WOUND CONTRACTION; WOUND DRESSING; WOUND HEALING; WOUND HEALING IMPAIRMENT;

EID: 77953461268     PISSN: None     EISSN: 11787007     Source Type: Journal    
DOI: None     Document Type: Note

References (31)

1. Yue DK, Swanson B, McLennan S, Marsh M. Abnormalities of granulation tissue and collagen formation in experimental diabetes. Diab Med. 1986;3:221-225.
2. Bitar MS, Ziad N, Labbad N. Transforming growth factor beta and insulin-like growth factor-1 in relation to diabetes-induced impairment of wound healing. J Surg Res. 1996;61:113-119.
3. Waugh HV, Sherratt JA. Macrophage dynamics in diabetic wound dealing. Bull Math Biol. 2006;68:197-207.
4. Liu R, Bal HS, Desta T, Behl Y, Graves DT. Tumor necrosis factor-alpha mediates diabetes-enhanced apoptosis of matrix-producing cells and impairs diabetic healing. Am J Pathol. 2006;168:757-764.
5. O'Connor JC, Johnson DR, Freund GG. Psychoneuroimmune implications of type 2 diabetes. Neurol Clin. 2006;24:539-559.
6. Goren I, Kampfer H, Podda M, Pfeilschifter J, Frank S. Leptin and wound inflammation in diabetic ob/ob mice: differential regulation of neutrophil and macrophage influx and a potential role for the scab as a sink for inflammatory cells and mediators. Diabetes. 2003;52:2821-2832.
7. Pinto FA, Malucelli BE. Inflammatory infiltrate, VEGF, and FGF-2 contents during corneal angiogenesis in STZ-diabetic rats. Angiogenesis. 2002;5:67-74.
8. Goren I, Muller E, Pfeilschifter J, Frank S. Severely impaired insulin signaling in chronic wounds of diabetic ob/ob mice: a potential role of tumor necrosis factor-alpha. Am J Pathol. 2006;68:765-777.
9. Fahey TJ, Sadaty A, Jones WG, Barber A, Smoller B, Shires GT. Diabetes impairs the late inflammatory response to wound healing. J Surg Res. 1991;50:308-313.
10. Norman MU, Hickey MJ. Mechanisms of lymphocyte migration in autoimmune disease. Tissue Antigens. 2005;66:163-172.
11. American Diabetes Association. Diabetes 2002 Vital Statistics. Alexandria, VA: American Diabetes Association; 2002.
12. Hinchliffe RJ, Valk GD, Apelqvist J, et al. A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes. Diabetes Metab Res Rev. 2008:S119-S144.
13. Matos TJ, Duarte CB, Goncalo M, Lopes MC. DNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cells. J Dermatol Sci. 2005;39:113-123.
14. Hildesheim J, Awwad RT, Fornace AJ Jr. p38 mitogen-activated protein kinase inhibitor protects the epidermis against the acute damaging effects of ultraviolet irradiation by blocking apoptosis and inflammatory responses. J Invest Dermatol. 2004;122:497-502.
15. Medicherla S, Protter AA, Ma JY, et al. Preventive and therapeutic potential of p38 alpha-selective mitogen-activated protein kinase inhibitor in nonobese diabetic mice with type 1 diabetes. J Pharmacol Exp Ther. 2006;318:99-107.
16. Medicherla S, Ma JY, Mangadu R, et al. A selective p38 alpha mitogen activated protein kinase inhibitor reverses cartilage and bone destruction in mice with collagen induced arthritis. J Pharmacol Exptl Ther. 2006;318:132-141.
17. Nguyen AN, Stebbins EG, Henson M, et al. Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppress osteoclast formation. Exp Cell Res. 2006;312:1909-1923.
18. Navas TA, Mohindru M, Estes M, et al. Inhibition of over activated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitors. Blood. 2006;108:4170-4177.
19. Ohura N, Kurita T, Takushima A, Shibata M, Harii K. Efficacy of skin-protection powder for use as a dressing intractable ulcers. J Wound Care. 2006;15:471-476.
20. Toyama T, Ohura N, Kurita M, Momosawa A, Harri K. Effectiveness of short-contact topical tretinoin in promoting wound healing in db/db mice. Scand J Plast Reconstr Surg Hand Surg. 2006;40:329-334.
21. Hart J, Silcock D, Gunnigle s, Cullen B, Light ND, Watt PW. The role of oxidized regenerated cellulose/collagen in wound repair: effects in vitro on fibroblast biology and in vivo in a model of compromised healing. Int J Biochem Cell Biol. 2002;34:1557-1570.
22. Lobmann R, Zemlin C, Motzkau M, Reschke K, Lehnert H. Expression of matrix metalloproteinases and growth factors in diabetic foot wounds treated with a protease absorbent dressing. J Diabetes Complications. 2006;20:329-335.
23. Kumar S, McDonnell PC, Gum RJ, Hand AT. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specificity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun. 1997;235:533-538.
24. Stvensson CI, Medicherla S, Malkmus S, et al. Spinal and DRG p38 MAP kinase in osteosarcoma pain model. Pharmacol Biochem Behav. 2008;90:664-675.
25. Vanderkerken K, Medicherla S, Coulton L, Protter AA, Higgins LS, Croucher PI. Inhibition of p38 MAPK prevents the development of myeloma bone disease, reduces tumor burden and increases survival in murine models of myeloma, Cancer Res. 2007;67:4572-4577.
26. Dobreva I, Waeber G, James RW, Widmann C. Interleukin-8 secretion by fibroblasts induced by low density lipoproteins is p38 MAPK dependent and leads to cells spreading and wound closure. J Biol Chem. 2006;281:199-205.
27. Alikhani M, Maclellan C, Raptis M, Vora S, Trackman P, Graves D. Advanced glycation end products induced apoptosis in fibroblasts through activation of ROS, MAP kinases and FOXO1 transcription factor. Am J Physiol Cell Physiol. 2007;292:C850-856.
28. Collins QF, Xiong Y, Lupo EG, Liu HY, Cao W. p38 mitogen-activated protein kinase mediates free fatty acid-induced gluconeogenesis in hepatocytes. J Biol Chem. 2006;281:24336-24344.
29. Mansfied PJ, Hinkovska-Galcheva V, Carey SS, Shayman JA, Boxer LA. Regulation of polymorphonuclear leukocyte degranulation and oxidant production by ceramide through inhibition of phospholipase D. Blood. 2002;99:1434-1441.
30. Hirano S, Rees RS, Gilmont RR. MAP kinase pathways involving hsp27 regulates fibroblast-mediated wound contraction. J Surg Res. 2002;102:77-84.
31. Yavuz D, Tugtepe H, Cetinel S, et al. Collagen ultra structure and TGF beta1 expression preserved with aminoguanidine during wound healing in diabetic rats. Endocr Res. 2005;31:229-243.